BioSpace News Archive

Evogene Ltd. today announced its financial results for the fourth quarter and full year period ending December 31, 2022.

GT Medical Technologies, Inc. announced its latest roster of ELITE Brain Tumor Centers that have received the distinction for completing 10 or more GammaTile Therapy procedures in 2022.

Alnylam Pharmaceuticals, Inc. and Medison Pharma have announced an expansion of their existing partnership to a multi-regional agreement that includes Poland, Czech Republic, Hungary, Slovakia, Lithuania, Estonia and Latvia, in addition to Israel.

Theseus Pharmaceuticals, Inc. today announced business highlights and reported financial results for the fourth quarter and full year ended December 31, 2022.

Candesant Biomedical today announced the acceptance of its pivotal SAHARA clinical trial data for its investigational targeted alkali thermolysis (TAT) Patch in a late-breaking oral presentation at the 2023 annual meeting of the American Academy of Dermatology (AAD), on March 18, 2023 in New Orleans, LA.

Positive high-level results from a planned interim analysis of the AEGEAN Phase III, placebo-controlled trial showed that treatment with AstraZeneca’s IMFINZI ®.

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will provide a corporate presentation at the Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15, 2023 at 8:40 a.m. ET.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, and Nick Harvey, Chief Financial Officer, will participate in the 2023 Jefferies Biotech on the Bay Summit being held March 16-17, 2023.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today reported its financial results for the fourth quarter and full year ended December 31, 2022.

Amedisys, Inc. today announced that Paul Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Acting Chief Operating Officer, Executive Vice President and Chief Financial Officer, will present at Oppenheimer’s 33rd Annual Healthcare Conference on March 14th at 10:00 a.m. ET.